Who owns GT BIOPHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Gt Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Gt Biopharma stock

Who bought or sold GT BIOPHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Retirement Group 1.00 $4.000000 -98% Mar 2024
 View chart

Who sold out of Gt Biopharma?

Fund or Company Name Date Sold Shares Held Valued At
Vanguard Group Dec 2023 1.1M $277k
Bank Of Montreal Dec 2023 596k $170k
Geode Capital Management Sep 2023 337k $81k
BlackRock Sep 2023 304k $73k
Wells Fargo & Company Dec 2023 301k $77k
Atria Wealth Solutions Dec 2023 99k $25k
Bank of New York Mellon Dec 2023 95k $24k
Millennium Management Dec 2023 66k $17k
Citadel Advisors Dec 2023 58k $15k
Two Sigma Securities Dec 2023 37k $9.5k
Hrt Financial Dec 2023 34k $8.0k
Northern Trust Sep 2023 32k $7.8k
Goldman Sachs Group Dec 2023 23k $5.8k
Tower Research Capital Sep 2023 20k $4.9k
Moss Adams Wealth Advisors Dec 2023 20k $5.1k
Jane Street Dec 2023 19k $4.9k
UBS Group Dec 2023 15k $3.5k
Susquehanna International Sep 2023 14k $3.4k
Commonwealth Equity Services Dec 2023 10k $3.0k
Welch Group Dec 2023 10k $2.6k
Morgan Stanley Sep 2023 8.1k $1.9k
Royal Bank of Canada Dec 2023 2.2k $0
Bank of America Corporation Dec 2023 1.1k $0
Advisor Group Holdings Dec 2023 1.0k $253.233000
Simplex Trading Dec 2023 304.00 $0
Blue Bell Private Wealth Management Dec 2023 300.00 $77.010000
FMR Sep 2023 150.00 $36.000000
Jpmorgan Chase & Co Dec 2023 16.00 $4.000000
Qube Research & Technologies Sep 2023 2.00 $0